Physician profile
Michael D Katz
NPI 1922160068
$1,887.55
in general payments reported to CMS, 2019-2025
8 companies · $447 in 2025
The $447 reported for 2025 was more than what a typical Neurology With Special Qualifications In Child Neurology provider received nationally (typical 2025 total: $275).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2021: $118 · 2022: $440 · 2023: $444 · 2024: $335 · 2025: $447.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,226.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $1,568.57 | 2021-2025 | Carto 3, Qdot Micro Catheter, Nuvision Ice Catheter |
| Biomarin Pharmaceutical INC. | $153.64 | 2024 | Brineura |
| Abbvie INC. | $62.22 | 2022 | |
| Aquestive Therapeutics, INC. | $40.61 | 2019 | |
| Ucb Sa | $26.10 | 2019 | |
| Shire North American Group INC | $13.21 | 2019 | |
| Eisai INC. | $12.27 | 2019 | |
| Ironshore Pharmaceuticals INC. | $10.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Katz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.